Trial NCT01648101

View at ClinicalTrials.gov 
Org. Study IDs: 114855

Last trial update was posted on 2018-08-13

MeSH Interventions

Ezogabine

MeSH Conditions

Epilepsy Seizures

Other Conditions


Stopping Reasons

Registration of the medicine is no longer being pursued in South Korea, Taiwan or Vietnam

Limitations And Caveats

RTG114855 was designed for registration of retigabine as add-on treatment of drug-resistant POS in South Korea/Taiwan/ Vietnam. GSK decided not to pursue registration in these countries and terminated the study early based on new safety information.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID